beta

ARWR

Arrowhead Pharmaceuticals Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

arrowhead pharmaceuticals is a clinical stage, nasdaq listed (ticker arwr) company developing medicines that treat intractable diseases by silencing the genes that cause them. using a broad portfolio of rna chemistries and efficient modes of delivery, our therapies trigger the rna interference mechanism to induce rapid, deep and durable knockdown of target genes. rna interference, or rnai, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. our rnai-based therapeutics are at the leading edge of genetic-based therapy with the potential to bring life changing treatments for patients. our targeted rnai molecule (trimtm) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. the trim platform builds on more than a decade of work on actively targeted drug delivery and offers several advantages including simplified manufacturing

Market Cap: 4.39 Billion

Primary Exchange: NASDAQ

Website: http://arrowheadpharma.com/

Shares Outstanding: 124 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 1.1142385654189453

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Ethical Flags

Longest drawdown: 2245 trading days

From: 2014-03-10 To: 2019-06-05

Lowest Point:

Winning Bounce/Lag Momentum Stocks For Week 24 Of 2019 (6/10-6/14)

via: SeekingAlpha at 2019-06-10 08:46:09:000

This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. The Bounce/Lag… read more...

Winning Bounce/Lag Momentum Stocks For Week 24 Of 2019 (6/10-6/14)

via: SeekingAlpha at 2019-06-10 08:46:09:000

This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. The Bounce/Lag… read more...

Winning Bounce/Lag Momentum Stocks For Week 24 Of 2019 (6/10-6/14)

via: SeekingAlpha at 2019-06-10 08:46:09:000

This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. The Bounce/Lag… read more...

Winning Bounce/Lag Momentum Stocks For Week 24 Of 2019 (6/10-6/14)

via: SeekingAlpha at 2019-06-10 08:46:09:000

This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. The Bounce/Lag… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud